Citadel Advisors’s Compugen CGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $150K | Buy |
+70,200
| New | +$136K | ﹤0.01% | 11684 |
|
|
2025
Q4 | – | Sell |
-13,700
| Closed | -$20.1K | – | 12777 |
|
|
2025
Q3 | $20.1K | Sell |
13,700
-44,100
| -76% | -$65.5K | ﹤0.01% | 12488 |
|
|
2025
Q2 | $103K | Buy |
57,800
+30,600
| +113% | +$45.4K | ﹤0.01% | 11325 |
|
|
2025
Q1 | $39.7K | Buy |
27,200
+2,600
| +11% | +$5.08K | ﹤0.01% | 12546 |
|
|
2024
Q4 | $37.6K | Buy |
24,600
+15,200
| +162% | +$24.7K | ﹤0.01% | 12662 |
|
|
2024
Q3 | $17K | Sell |
9,400
-8,200
| -47% | -$15K | ﹤0.01% | 12904 |
|
|
2024
Q2 | $29.6K | Buy |
17,600
+4,200
| +31% | +$8.75K | ﹤0.01% | 12290 |
|
|
2024
Q1 | $34.6K | Sell |
13,400
-18,500
| -58% | -$43.1K | ﹤0.01% | 12550 |
|
|
2023
Q4 | $63.2K | Buy |
31,900
+14,300
| +81% | +$12.5K | ﹤0.01% | 11528 |
|
|
2023
Q3 | $16.4K | Buy |
17,600
+800
| +5% | +$880 | ﹤0.01% | 12780 |
|
|
2023
Q2 | $19.2K | Buy |
+16,800
| New | +$14.6K | ﹤0.01% | 12761 |
|
|
2023
Q1 | – | Sell |
-44,800
| Closed | -$32.1K | – | 14780 |
|
|
2022
Q4 | $32.1K | Buy |
44,800
+11,200
| +33% | +$9.77K | ﹤0.01% | 12656 |
|
|
2022
Q3 | $22K | Buy |
+33,600
| New | +$47.5K | ﹤0.01% | 12032 |
|
|
2022
Q2 | – | Sell |
-17,000
| Closed | -$55K | – | 12966 |
|
|
2022
Q1 | $55K | Sell |
17,000
-3,700
| -18% | -$12.5K | ﹤0.01% | 12729 |
|
|
2021
Q4 | $89K | Sell |
20,700
-47,100
| -69% | -$255K | ﹤0.01% | 12826 |
|
|
2021
Q3 | $405K | Buy |
67,800
+21,800
| +47% | +$146K | ﹤0.01% | 10379 |
|
|
2021
Q2 | $381K | Sell |
46,000
-41,700
| -48% | -$339K | ﹤0.01% | 10686 |
|
|
2021
Q1 | $753K | Sell |
87,700
-11,200
| -11% | -$124K | ﹤0.01% | 8782 |
|
|
2020
Q4 | $1.2M | Buy |
98,900
+23,700
| +32% | +$327K | ﹤0.01% | 6408 |
|
|
2020
Q3 | $1.22M | Sell |
75,200
-3,900
| -5% | -$63.9K | ﹤0.01% | 5666 |
|
|
2020
Q2 | $1.19M | Buy |
79,100
+26,400
| +50% | +$356K | ﹤0.01% | 5510 |
|
|
2020
Q1 | $383K | Buy |
52,700
+41,000
| +350% | +$322K | ﹤0.01% | 6906 |
|
|
2019
Q4 | $70K | Sell |
11,700
-4,800
| -29% | -$24.7K | ﹤0.01% | 8672 |
|
|
2019
Q3 | $70K | Buy |
16,500
+1,000
| +6% | +$3.74K | ﹤0.01% | 8611 |
|
|
2019
Q2 | $60K | Buy |
+15,500
| New | +$54.8K | ﹤0.01% | 8670 |
|
|
2016
Q1 | – | Sell |
-5,000
| Closed | -$32K | – | 6869 |
|
|
2015
Q4 | $32K | Buy |
5,000
+2,700
| +117% | +$17.7K | ﹤0.01% | 7622 |
|
|
2015
Q3 | $12K | Sell |
2,300
-1,000
| -30% | -$5.83K | ﹤0.01% | 8397 |
|
|
2015
Q2 | $23K | Buy |
3,300
+2,500
| +313% | +$17.5K | ﹤0.01% | 8080 |
|
|
2015
Q1 | $6K | Sell |
800
-800
| -50% | -$6.54K | ﹤0.01% | 8290 |
|
|
2014
Q4 | $13K | Sell |
1,600
-1,900
| -54% | -$14.6K | ﹤0.01% | 8029 |
|
|
2014
Q3 | $30K | Sell |
3,500
-1,500
| -30% | -$13.3K | ﹤0.01% | 7215 |
|
|
2014
Q2 | $45K | Buy |
5,000
+4,200
| +525% | +$37.8K | ﹤0.01% | 6813 |
|
|
2014
Q1 | $8K | Buy |
+800
| New | +$8.81K | ﹤0.01% | 7572 |
|
Other funds holding CGEN
SCM
AIM
NAMI
TFCM
YLHM
Citadel Advisors's CGEN Position: Q1 2026 in Review
Citadel Advisors reduced its Compugen (CGEN) stake by 28% in Q1 2026, selling an estimated $86.8K and leaving 112,393 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #11013.
Citadel Advisors first reported a position in CGEN in Q1 2014 and has held it in 39 quarters since. The position peaked at $5.7M in Q1 2020. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.
- Citadel Advisors held 112,393 shares of Compugen worth $239K as of Q1 2026.
- Citadel Advisors sold 44,722 Compugen shares in Q1 2026, an estimated $86.8K.
- Compugen made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11013 holding.
- Citadel Advisors first reported a position in Compugen in Q1 2014 and has held it in 39 quarters since.
- Citadel Advisors's Compugen position peaked at $5.7M in Q1 2020.
- 78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.